Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM474989 (US10849901, Compound 39 | US10953012, Example 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487173 (2-(4-Chloro-phenyl)-5-methyl-4H-pyrazolo[1,5-a]pyr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487174 (6-Benzyl-3-(4-chloro-phenyl)-5-methyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487175 (2-(3-Bromo-phenyl)-5-methyl-4H-pyrazolo[1,5-a]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487176 (2-Benzyl-3-(4-methoxy-phenyl)-5-phenyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487177 (3-(4-Methoxy-phenyl)-2-methyl-5-phenyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM475045 (US10849901, Compound 95 | US10953012, Example 7) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487179 (3-(4-Chloro-phenyl)-2-methyl-5-phenyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM50168142 (CHEMBL3716578 | US10849901, Compound 38 | US109530...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase CHEMBL MCE PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM474979 (US10849901, Compound 29 | US10953012, Example 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487184 (2-Benzyl-3-naphthalen-1-yl-5-phenyl-4H-pyrazolo[1,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487185 (2-(4-Methoxy-benzyl)-3,5-diphenyl-4H-pyrazolo[1,5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487186 (2-Methyl-7-oxo-3,5-diphenyl-4,7-dihydro-pyrazolo[1...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487187 (5-(4-Methoxy-phenyl)-2-methyl-3-phenyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487188 (3-(4-Fluoro-phenyl)-2-methyl-5-phenyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM50260215 (CHEMBL3717926 | US10953012, Example 16) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem Similars | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487191 (5-(4-Chloro-phenyl)-2-methyl-3-phenyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487192 (2-Benzyl-3-(4-chloro-phenyl)-5-propyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487193 (2-Benzyl-5-methoxymethyl-3-(4-methoxy-phenyl)-4H-p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487196 (3-(4-Chloro-phenyl)-2-methyl-5-propyl-4H-pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487177 (3-(4-Methoxy-phenyl)-2-methyl-5-phenyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487195 (2,5-Dibenzyl-3-phenyl-4H-pyrazolo[1,5-a]pyrimidin-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487197 (5-Benzyl-3-(4-methoxy-phenyl)-2-methyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487198 (2-Benzyl-3-(4-chloro-phenyl)-5-methoxymethyl-4H-py...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM474979 (US10849901, Compound 29 | US10953012, Example 25) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487200 (2-Benzyl-3-(4-chlorophenyl)-6,7-dihydro-4H-cyclope...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487201 (3-(4-Chlorophenyl)-2-methyl-6,7-dihydro-4H-cyclope...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487202 (3-(4-Chloro-phenyl)-2,5-dimethyl-4H-pyrazolo[1,5-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487203 (2-(4-Chloro-phenyl)-5-methoxymethyl-4H-pyrazolo[1,...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487204 (5-Isopropyl-2-(4-methoxy-phenyl)-3-phenyl-4H-pyraz...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487205 (2-(4-Methoxy-benzyl)-5-methyl-3-phenyl-4H-pyrazolo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487206 (6-Ethyl-2-(4-methoxy-benzyl)-5-methyl-3-phenyl-4H-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487207 (3-(4-Chloro-phenyl)-6-ethyl-2,5-dimethyl-4H-pyrazo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM475039 (US10849901, Compound 89 | US10953012, Example 34) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487209 (2,3-Diphenyl-6,7-dihydro-4H-cyclopenta[d]pyrazolo[...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487210 ((7-oxo-2,3-diphenyl-4,7-dihydro-pyrazolo[1,5-a]pyr...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487215 (2-Methyl-3-phenyl-5-p-tolyl-4H-pyrazolo[1,5-a]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487216 (3-(4-Fluoro-phenyl)-5-(4-methoxy-phenyl)-2-methyl-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487175 (2-(3-Bromo-phenyl)-5-methyl-4H-pyrazolo[1,5-a]pyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 1: One assay for purified hPASK activity utilizes the Kinase-Glo Luminescent Kinase Assay (Promega), which quantifies the amount of ATP remaini... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487219 (5-(4-Methoxyphenyl)-2-methyl-3-propylpyrazolo[1,5-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487220 (5-(4-Methoxyphenyl)-3-(pyridin-3-yl)pyrazolo[1,5-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487221 (3-Benzyl-2-methyl-5-(quinolin-6-yl)pyrazolo[1,5-a]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487222 (3-Benzyl-5-(1H-indol-6-yl)-2-methylpyrazolo[1,5-a]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487223 (3-(3-Chlorobenzyl)-5-(benzo[d][1,3]dioxol-5-yl)-2-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487224 (3-(4-Chlorobenzyl)-5-(benzo[d][1,3]dioxol-5-yl)-2-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487225 (3-(4-Fluorophenyl)-2-methyl-5-(pyridin-3-yl)pyrazo...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487226 (3-(4-Fluorophenyl)-5-(pyridin-2-yl)pyrazolo[1,5-a]...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487227 (5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-(4-fluor...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487228 (5-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-(3-metho...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
PAS domain-containing serine/threonine-protein kinase [879-1323] (Homo sapiens (Human)) | BDBM487229 (5-(Benzofuran-2-yl)-3-(pyridin-2-yl)pyrazolo[1,5-a...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
BioEnergenix LLC US Patent | Assay Description Table 2: Purified PASK (UniProt #Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration... | US Patent US10953012 (2021) BindingDB Entry DOI: 10.7270/Q22F7RJN | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 363 total ) | Next | Last >> |